10 key questions about monkeypox the world needs to answer; first U.S. death tied to monkeypox reported

Scant attention paid to monkeypox for decades means there are big unanswered questions about the disease and the virus that causes it. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        10 key questions about monkeypox the world needs to answer By Megan Molteni and Helen Branswell and Andrew Joseph and Jason Mast NIAID STAT reporters examine some of the most pressing questions about the disease and the virus that causes it. Read More Texas reports death tied to monkeypox, a first in the U.S. By Andrew Joseph NIAID The unidentified person was a resident of Harris County and was "severely immunocompromised," according to the state health department. Read More STAT+: In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons By Tara Bannow Adobe Patient advocacy groups are challenging a federal regulation they say prevents patients from using drugmaker discounts. Read More Sponsor content by ALNYLAM PHARMACEUTICALS "Silencing" the expression of disease-causing genes using RNA interference (RNAi) During gene expression, errors in DNA can result in faulty mRNA that cause or contribute to disease. Alnylam's RNAi therapeutics utilize specially designed small interfering RNA (siRNA) to target and degrade these mRNA, treating disease at source. Learn how. Opinion: 'Whose life do I prioritize?' A choice no parent wants to make By Christopher Hartnick Adobe In some pregnancies, a mother must weigh her own risks and benefits with those of her unborn child. It's a terribly difficult choice. Read More Unprecedented! Incredible! Scientific grant applications are getting heavier on hype By Theresa Gaffney Alex Hogan/STAT New research finds that adjectives that convey hype are growing increasingly common in successful grant applications to the NIH. Read More Opinion: Five years after Kymriah: Ensuring the next cell and gene therapies reach patients By Lung-I Cheng Adobe Kymriah, the first cell and gene therapy, was approved five years ago. It will take work to get the next wave of these therapies to patients. Read More Tuesday, August 30, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser